Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lanqin Oral Liquid
- Development stage
- Unknown
- Lead developer
- Yangtze River Pharmaceutical Group
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Lanqin Oral Liquid is a Traditional Chinese Medicine (TCM) formulation widely used in China for the treatment of upper respiratory tract infections and viral diseases. It is composed of five herbal ingredients: *Isatis tinctoria* (Banlangen), *Scutellaria baicalensis* (Huangqin), *Gardenia jasminoides* (Zhizi), *Phellodendron amurense* (Huangbai), and *Sterculia lychnophora* (Pangdahai). The preparation is primarily indicated for acute pharyngitis and tonsillitis characterized by symptoms such as sore throat, fever, and cough. Clinical research has also explored its efficacy in treating Hand, Foot, and Mouth Disease (HFMD) in pediatric patients. Its therapeutic effects are attributed to its broad-spectrum antiviral, antibacterial, and anti-inflammatory properties, which help alleviate mucosal inflammation and inhibit viral replication.
- Brand names
- Lanqin Oral Liquid
- Other names
- Lanqin KoufuyeLanqin Oral Solution
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on Lanqin Oral Liquid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lanqin Oral Liquid.